Clinical trial for Residual Gastric Contents
Official title Effect of Fasting Recommendations Among Patients Using GLP-1 Receptor Agonists
ClinicalTrials.gov ID: NCT06839248
What this study is testing
- What it's testing
- This study wants to find out if drinking only clear liquids for 24 hours before a test leaves less food in the stomach than standard fasting rules. It also checks how hungry or thirsty participants feel.
- Who it's for
- Adults who currently take a once-weekly medication called a GLP-1 receptor agonist.
- What's involved
- Participants will follow either a clear liquid diet or standard fasting rules for 24 hours. They will then come in for a stomach ultrasound to check for leftover food.
- Time commitment
- The study involves a 24-hour preparation period followed by a single visit for testing.
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Age ≥18 years old at enrolment.
- Have regularly administered any type of once-weekly GLP-1 RA medication for a period of at least one month prior to randomisation.
- If allocated to follow standard fasting guidelines, willing to adhere to ASA and ANZCA preoperative fasting requirements.
- If allocated to follow a 24-hour clear liquid diet, willing to adhere to nothing-by-mouth (NPO) for solids and last intake of clear liquids no less...
- Provide a signed and dated informed consent form for study participation in line with the requirements of the human research ethics committee (HREC)...
You likely can't join if
- Has a recent history of gastrointestinal bleed within the previous 1 month from enrolment.
- Has a history of previous lower oesophageal or gastric surgery.
- Participant reports having been previously diagnosed with a clinically significant gastric emptying abnormality such as gastroparesis.
- Participant reports concomitant use of insulin.
- Unable to assume the right lateral decubitus position required for gastric ultrasound assessment.
- Participant has difficulty fully understanding PICF or study materials due to a primary language other than English.
The study team makes the final eligibility decision.
Where it is enrolling
- Melbourne, Victoria, Australia
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Melbourne, Victoria, Australia. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.